I’ve been at ADAMAS for over two years now, and am Head of Practice, Computer Systems Compliance. There are many things I enjoy about my job and respect about the company I work for. Firstly, there’s our people and their undeniable expertise; there isn’t anyone here...
As Executive Director of Pharmacovigilance at ADAMAS, it would be fair to assume that I am responsible for maintaining our Good Pharmacovigilance Practice (GVP) service provision and ensuring our clients’ needs are catered for. While that is true, it doesn’t just end...
21CFR11 Compliance of Third-Party Computer Systems
The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.
ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.